Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 08/24 07:45:50 pm
43.855 USD   -0.10%
03:01p ABBOTT : to Present at Wells Fargo Healthcare Conference
08/09 ABBOTT LABORATO : still not happy with Alere even though financials ..
08/08 ABBOTT LABORATO : California State Teachers Retirement System Lowers..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 94322 11923 396
Operating income (EBITDA)4 9745 8624 8505 0425 4445 867
Operating profit (EBIT)4 0464 3143 9793 9894 4634 789
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4232 3233 3323 614
P/E ratio23,730,215,424,519,117,2
EPS ( $ )1,621,492,921,792,302,55
Dividend per Share ( $ )0,640,900,981,041,141,24
Yield1,67%2,00%2,18%2,37%2,60%2,82%
Reference price ( $ )38.3345.0244.9143.943.943.9
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8762 6993 1922 990
Finance------
Operating income (EBITDA)4 9745 8624 8505 0425 4445 867
Leverage
(Debt/EBITDA)
0,62x0,65x0,59x0,54x0,59x0,51x
Capital Expenditure1 1451 0771 1101 1831 1661 261
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $13,1 $16,5 $17,8 $
Cash Flow per Share2,11 $2,41 $1,97 $2,41 $3,32 $3,48 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 64 533 M$ -
Entreprise Value (EV) 67 231 M$ 67 725 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 24,5x 19,1x
Capitalization / Revenue 3,08x 2,92x
EV / Revenue 3,21x 3,06x
EV / EBITDA 13,3x 12,4x
Yield (DPS / Price) 2,37% 2,60%
Price to book (Price / BVPS) 3,34x 2,66x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,0% 20,2%
operating Leverage (Delta EBIT / Delta Sales) 0,10x 2,11x
Net Margin (Net Profit / Revenue) 11,1% 15,1%
ROA (Net Profit / Asset) 7,78% 9,49%
ROE (Net Profit / Equities) 15,8% 15,9%
Rate of Dividend 58,1% 49,7%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   5,65% 5,27%
Cash Flow / Sales 16,9% 22,1%
Capital Intensity (Assets / Sales) 1,43x 1,59x
Financial Leverage (Net Debt / EBITDA) 0,54x 0,59x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend